ClinicalTrials.Veeva

Menu
T

Tidewater Clinical Research | Virginia Beach, VA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Estradiol
butoconazole nitrate
Elagolix
clindamycin phosphate
Progesterone
Amolimogene
Desvenlafaxine
Paroxetine
OG-6219
Escitalopram

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 22 total trials

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain (ELENA)

The purpose of this global Phase 2 study is to determine the efficacy, safety, and tolerability of 3 dose levels of OG-6219 in pre-menopausal women b...

Enrolling
Endometriosis
Drug: Placebo
Drug: OG-6219

A Phase 3, multi-center clinical trial of a CCT-102 regimen compared to expectant management to promote uterine evacuation in first trimester non-pro...

Enrolling
Early Pregnancy Loss, Delayed Pregnancy Loss
Combination Product: CCT-102 A and CCT-102 B

This is a two-part study designed to evaluate the effect of Estetrol (E4) 15 or 20 mg, or placebo on the severity and frequency of vasomotor symptoms...

Active, not recruiting
Menopausal Symptoms
Vasomotor Symptoms
Drug: Progesterone oral tablet
Drug: Estetrol oral tablet

This is phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menst...

Active, not recruiting
Uterine Fibroids
Heavy Menstrual Bleeding
Other: E2/NETA Placebo
Drug: E2/NETA

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling
Endometriosis
Drug: Elagolix
Drug: Placebo

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic...

Active, not recruiting
Contraception
Device: ESSURE (BAY1454032)
Procedure: Laparoscopic tubal sterilization

The primary objective of this study is to evaluate the safety and efficacy of the Zip-stitch® Vaginal Cuff Closure System. This will be primarily don...

Enrolling
Laparoscopic Hysterectomy
Device: Zip-stitch(R)
Device: Reference suture

Trial sponsors

AbbVie logo
T
L
Organon logo
Alcon logo
A
Astellas logo
Bayer logo
Becton, Dickinson and Company (BD) logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems